Meg is the Group Editorial Director for Cannabis Patient Care and Cannabis Science and Technology magazines at MJH Life Sciences.
November 02, 2020
Welcome to the first edition of Cannabis Patient Care!
Stephen Mandile—veteran, cannabis patient, and advocate—shares his personal experience with medical cannabis and how it has given him a new mission to help other veterans gain access to this plant.
An in-depth conversation with Dr. Staci Gruber, Director of the Cognitive and Clinical Neuroimaging Core, Director of Marijuana Investigations for Neuroscientific Discovery (MIND) at McLean Hospital, and Associate Professor of Psychiatry at Harvard Medical School on her interest in medical cannabis and the medical cannabis research areas that MIND is focusing on for veterans and beyond.
February 04, 2020
Dr. Sue Sisley has been pioneering research in the U.S. cannabis industry and fighting for quality cannabis samples to conduct her clinical trials. We recently spoke to her about the challenges she’s faced, what’s ahead for her future research, and more.
November 04, 2019
Aryn Sieber, the founder and CEO of CBD Essentials and Cannaisseur Brands as well as the founder of CannaCauses Foundation, discusses his experiences as a 9/11 first responder, his battle with stage IV cancer, and how cannabis impacted his life.
March 27, 2019
David L. Nathan, MD, DFAPA, President, Board of Directors, Doctors for Cannabis Regulations (DFCR), discusses how the DFCR was formed, the efforts they have been making in the cannabis field, and plans for the future of the organization.
February 08, 2019
Here we take a closer look at Australia’s medical cannabis program, the laws surrounding it, and speak to Australian pharmacist Paul Mavor.
February 01, 2019
Paul Mavor, an Australian and UK licensed pharmacist and the CEO and Founder of Health House International, recently spoke to us about Australia’s medical cannabis program, the testing and regulations in place, and the future outlook for cannabis in his country.